Difficulty: Medium
Average Score: 74%
Practice
The following drug is a quick relief medication for acute bronchial asthma
Correct answer
A
Rationale
In the context of respiratory pharmacology, the correct answer to the question is option A) Inhaled salbutamol. Salbutamol is a short-acting beta agonist that acts quickly to relieve bronchospasm, making it an ideal choice for acute bronchial asthma exacerbations. When inhaled, salbutamol works by relaxing the smooth muscles in the airways, leading to bronchodilation and improved airflow.
Option B) Montelukast is a leukotriene receptor antagonist, which is more commonly used for maintenance therapy in asthma to prevent symptoms rather than for quick relief during acute attacks.
Option C) Nedocromil is a mast cell stabilizer that is also used for maintenance therapy in asthma and is not typically used for immediate relief of bronchospasm.
Option D) Oral theophylline is a bronchodilator, but its use has declined due to a narrow therapeutic window, potential for toxicity, and the availability of safer and more effective alternatives like inhaled beta agonists.
Educationally, understanding the differences between these medications is crucial for healthcare professionals managing patients with asthma. Knowing when to use quick-relief medications like salbutamol versus long-term control medications like montelukast can significantly impact patient outcomes and quality of life. It is important to grasp the mechanism of action, indications, contraindications, and potential side effects of each drug to make informed clinical decisions.
Option B) Montelukast is a leukotriene receptor antagonist, which is more commonly used for maintenance therapy in asthma to prevent symptoms rather than for quick relief during acute attacks.
Option C) Nedocromil is a mast cell stabilizer that is also used for maintenance therapy in asthma and is not typically used for immediate relief of bronchospasm.
Option D) Oral theophylline is a bronchodilator, but its use has declined due to a narrow therapeutic window, potential for toxicity, and the availability of safer and more effective alternatives like inhaled beta agonists.
Educationally, understanding the differences between these medications is crucial for healthcare professionals managing patients with asthma. Knowing when to use quick-relief medications like salbutamol versus long-term control medications like montelukast can significantly impact patient outcomes and quality of life. It is important to grasp the mechanism of action, indications, contraindications, and potential side effects of each drug to make informed clinical decisions.